Suche
Mein Konto
Shocking confession in Vaihingen: Atropine affair shocks emergency services!
In the case in Vaihingen, a 24-year-old confesses to having put atropine in a colleague's drinking bottle. Process details and consequences.
Shocking confession in Vaihingen: Atropine affair shocks emergency services!
On the last day of the trial in Vaihingen, the 24-year-old defendant made a partial confession. While she maintained that she was not involved in one of two cases, she confessed to putting atropine in a colleague's drinking bottle. These dramatic twists in the trial have caused a stir. The defendant justified her actions with her Christian faith, fear of discrimination and concern for her sick mother. She stressed that she had no intention of causing serious harm or death to her colleague, further complicating the situation.
Atropine is a toxic tropane alkaloid obtained from the black deadly nightshade (Atropa belladonna). It acts as a parasympatholytic, blocks muscarinic receptors and is used in medicine, especially in emergency and intensive care medicine, to accelerate a slow heartbeat. However, if used improperly, dangerous consequences can occur, even leading to serious poisoning, including redness, rapid heartbeat and loss of consciousness. The LD50 values for humans show how dangerous it is: just 100 mg can be fatal, while for children 2 to 10 mg are considered threatening.
Course of the trial and witness statements
On the sixth day of the trial, another witness was heard, a colleague from the rescue station, who stated that he had had a sexual relationship with the defendant. He reported that he was only marginally aware of what was going on. An incident that came up during the interview showed that the defendant had a flashback and appeared apathetic, further complicating the statements.
Defense attorney Jan Smollich has already received a release from confidentiality and plans to bring in additional documents and other witnesses about the defendant's medical and psychological background. According to information, several psychologists have studied the defendant intensively since 2013, which could be important for the upcoming negotiations.
In view of the complicated situation, it is foreseeable that the verdict, which was originally scheduled for October 29th, may not be announced as planned. This could indicate the need to extend the trial for another day of hearings.
The case not only raises legal questions, but also illuminates the psychological and social dimensions of actions that occur in stressful situations. While the debate surrounding the defendants' motives continues, it remains to be seen how the court will consider the various factors in its decision.
For detailed information about atropine and its effects, you can refer to the comprehensive description in the Wikipedia page above Atropine be referred. Further information on the current developments in the process can be found in the Bietigheim newspaper to find.